# Pre-operative Antihypertension Strategies-Carotid Artery Stenting

Study · id `cardio:ct-nct05905848` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05905848](<https://clinicaltrials.gov/study/NCT05905848>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05905848

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 560 participants.

## Technical summary

Registry record NCT05905848. Randomized; single masking; primary purpose prevention. Start 2023-06-15 (anticipated); primary completion 2025-05-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 560 participants (planned count; ClinicalTrials.gov record NCT05905848, source copy `cardio:ctgov-nct05905848-2023-06-15`, retrieved 2026-10-31)
- Planned start: 2023-06-15 (anticipated) (ClinicalTrials.gov record NCT05905848, source copy `cardio:ctgov-nct05905848-2023-06-15`, retrieved 2026-10-31)
- Primary completion: 2025-05-31 (anticipated) (ClinicalTrials.gov record NCT05905848, source copy `cardio:ctgov-nct05905848-2023-06-15`, retrieved 2026-10-31)
- Completion: 2025-07-31 (anticipated) (ClinicalTrials.gov record NCT05905848, source copy `cardio:ctgov-nct05905848-2023-06-15`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT05905848, source copy `cardio:ctgov-nct05905848-2023-06-15`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05905848-2023-06-15`, retrieved 2026-10-31)

## The registry's words

- Brief title: Pre-operative Antihypertension Strategies-Carotid Artery Stenting
- Acronym: PASS-CAS
- Condition: Carotid Stenosis
- Intervention (Drug): administering RASI (the trade name or universal name will not be stipulated) before stenting
- Intervention (Drug): administering CCB (the trade name or universal name will not be stipulated) before stenting
- Lead sponsor: West China Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Carotid artery stenosis (`cardio:carotid-stenosis`)
- Registry lists this organization as the lead sponsor: West China Hospital (`cardio:org-west-china-hospital`)

## Provenance

Content hash: 32485e95ef027962323817c6fee2894d97fae607da892f0872b852755798e0ec
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
